• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Clarivate Analytics Plc (NY: CLVT )

    6.985 +0.305 (+4.57%)
    Streaming Delayed Price Updated: 11:57 AM EDT, Sep 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 961,585
    Open 6.800
    Bid (Size) 6.980 (45)
    Ask (Size) 6.990 (10)
    Prev. Close 6.680
    Today's Range 6.770 - 6.995
    52wk Range 4.970 - 9.605
    Shares Outstanding 724,100,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Clarivate Partners With Libraries To Unveil AI Research Assistant, Boosting Academic Integrity And Discovery
    Clarivate launched Primo Research Assistant, which is a new generative AI-powered library discovery solution. Primo Research Assistant, part of the Primo Discovery solution, uses a Retrieval Augmented... 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga

    Performance

    YTD
    -23.07%
    -23.07%
    1 Month
    +4.41%
    +4.41%
    3 Month
    +22.54%
    +22.54%
    6 Month
    -6.37%
    -6.37%
    1 Year
    -0.64%
    -0.64%

    More News

    Read More
    CLVT Stock Earnings: Clarivate Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
    Via Benzinga
    Critical Insights From Clarivate Analyst Ratings: What You Need To Know
    Via Benzinga
    The Analyst Landscape: 5 Takes On Clarivate
    Via Benzinga
    Clarivate: The Cheapest AI Stock Worth Buying?
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Top 5 Stocks to Watch for AI-Driven Gains That Aren’t NVIDIA
    Via MarketBeat
    Why Is Clarivate Stock Trading Higher Premarket Monday?
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    CLVT Stock Earnings: Clarivate Meets EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    Preview: Clarivate's Earnings
    Via Benzinga
    The Latest Analyst Ratings for Clarivate
    Via Benzinga
    Analytics Firm Clarivate Acquires AI Start-Up MotionHall - What's On The Cards?
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Exor Amplifies Stake In Clarivate, Proposes New Board Member
    Via Benzinga
    S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday?
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Industrials Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Industrials Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Industrials Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Industrials Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Industrials Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Clarivate Buys Alethea, Creates Academia And Government Innovation Incubator
    Via Benzinga
    Clarivate Launches AI-Powered Tool For IP Forecasts And Budgets
    Via Benzinga
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
    Via Investor's Business Daily
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.